FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-108217.
(The FASEB Journal. 2008;22:2734-2739.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.08-108217v1
22/8/2734    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Metzner, C.
Right arrow Articles by Dangerfield, J. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metzner, C.
Right arrow Articles by Dangerfield, J. A.

Association of glycosylphosphatidylinositol-anchored protein with retroviral particles

Christoph Metzner*,{dagger},1, Meike M. Mostegl*,{ddagger}, Walter H. Günzburg*,{dagger},{ddagger}, Brian Salmons§,|| and John A. Dangerfield*,{ddagger},||

* Institute of Virology, University of Veterinary Medicine, Vienna, Austria;

{dagger} Christian Doppler Laboratory for Gene Therapeutic Vector Development, Vienna, Austria;

{ddagger} Christian Doppler Laboratory for Gene Therapeutic Vector Development, Foreign Module for Retroviral Nanotechnology, Singapore;

§ Austrianova Biomanufacturing, Vienna, Austria; and

|| Austrianova Singapore, Singapore

1Correspondence: Institute of Virology, University of Veterinary Medicine, Veterinärplatz 1, A-1210 Vienna, Austria. E-mail: christoph.metzner{at}vu-wien.ac.at

We describe for the first time the association of glycosylphosphatidylinositol (GPI) -anchored proteins with retroviral and lentiviral particles, similar to a process well established for cells, termed "painting." The aim of the study was to assess the feasibility of modification of retroviral vectors by exogenous addition of recombinant protein, removing the need for genetic engineering of virus producer cell lines. The recombinant GPI protein CD59his was purified via fast protein liquid chromatography and associated with concentrated virus stock in a controlled incubation procedure. Reaction mixtures were purified in order to remove nonassociated GPI protein and endogenous protein. Analysis of samples by immunoblotting revealed that CD59his was only detectable in the presence of viral particles. From this, we conclude that CD59his could be stably associated with retroviral particles. In addition, we demonstrated by flow cytometry that virus particles remain infectious after these procedures. As well as suggesting a novel possibility for interaction between enveloped virus and host, we believe that the stable association of recombinant GPI proteins to retroviral particles can be developed into an important tool for both research and clinical applications, especially in the fields of gene therapy and vaccine development.—Metzner, C., Mostegl, M. M., Günzburg, W. H., Salmons, B., Dangerfield, J. A. Association of glycosylphosphatidylinositol-anchored protein with retroviral particles.


Key Words: GPI • retrovirus • lentivirus • gene therapy • vaccine development







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.